Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Healthtrust
Merck
Daiichi Sankyo
Cipla
McKesson
Johnson and Johnson
Fuji
Deloitte

Generated: May 22, 2018

DrugPatentWatch Database Preview

AEROSPORIN Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

When do Aerosporin patents expire, and what generic alternatives are available?

Aerosporin is a drug marketed by Glaxosmithkline and is included in one NDA.

The generic ingredient in AEROSPORIN is polymyxin b sulfate. There are twelve drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the polymyxin b sulfate profile page.
Summary for AEROSPORIN
Drug patent expirations by year for AEROSPORIN
Medical Subject Heading (MeSH) Categories for AEROSPORIN
Synonyms for AEROSPORIN
1405-20-5
1405-20-5, 4135-11-9 (free base)
AB00053527_02
AB2000085
AC1L1J4Z
AC1NWAPL
Aerosporin, PMB, Poly-RX , 1405-20-5
Aerosporin;PMB;Poly-RX
AKOS015895662
AN-946
BSPBio_002197
C55H96N16O13.2H2SO4
CCG-39724
CHEMBL241797
DB00781
DivK1c_000732
FT-0654126
HFMDLUQUEXNBOP-UHFFFAOYSA-N
HMS1920J04
HMS2092A07
HMS502E14
I06-1086
I559
IDI1_000732
KBio1_000732
KBio2_001597
KBio2_004165
KBio2_006733
KBio3_001697
KBioGR_000961
KBioSS_001597
Listeria monocytogenes Selective Supplement I
MFCD00131991
MolPort-003-665-543
N-[3-amino-1-({1-[(3-amino-1-{[6,9,18-tris(2-aminoethyl)-15-benzyl-3-(1-hydroxyethyl)-12-(2-methylpropyl)-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptaazacyclotricosan-21-yl]carbamoyl}propyl)carbamoyl]-2-hydroxypropyl}ca
N-[3-amino-1-[[1-[[3-amino-1-[[6,9,18-tris(2-aminoethyl)-15-benzyl-3-(1-hydroxyethyl)-12-isobutyl-2,5,8,11,14,17,20-heptaketo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]carbamoyl]propyl]carbamoyl]-2-hydroxy-propyl]carbamoyl]p
N-[3-amino-1-[[1-[[3-amino-1-[[6,9,18-tris(2-aminoethyl)-15-benzyl-3-(1-hydroxyethyl)-12-isobutyl-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]carbamoyl]propyl]carbamoyl]-2-hydroxy-propyl]carbamoyl]pr
N-[4-amino-1-[[1-[[4-amino-1-oxo-1-[[6,9,18-tris(2-aminoethyl)-15-benzyl-3-(1-hydroxyethyl)-12-(2-methylpropyl)-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]amino]butan-2-yl]amino]-3-hydroxy-1-oxobuta
NCGC00094763-01
NCGC00094763-02
NCGC00178768-01
NINDS_000732
NSC-757278
NSC757278
Pharmakon1600-01500492
Polimixina B
Poly-RX
Polymixin B sulfate, Cell Culture Reagent
Polymixin B sulphate
Polymixin B-sulfate
polymyxin b
Polymyxin B sulfate
Polymyxin B sulfate salt
Polymyxin B sulphate
Polymyxin B sulphate salt
Polymyxin-B-Sulfat
Polymyxine B
Polymyxine B (sulfate de)
Polymyxini B sulfas
Polymyxinum B
s1395
SBI-0051486.P003
SCHEMBL7799155
SPBio_000359
Spectrum_001117
SPECTRUM1500492
Spectrum2_000490
Spectrum3_000549
Spectrum4_000481
Spectrum5_001331
SR-05000002074
SR-05000002074-2
sufuric acid

US Patents and Regulatory Information for AEROSPORIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Glaxosmithkline AEROSPORIN polymyxin b sulfate INJECTABLE;INJECTION 062036-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
Accenture
Cerilliant
McKesson
Healthtrust
Boehringer Ingelheim
McKinsey
Chinese Patent Office
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.